Terms: = Pancreatic cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Staging
975 results:
1. Multimodal Approaches to Patient Selection for Pancreas cancer Surgery.
Muaddi H; Kearse L; Warner S
Curr Oncol; 2024 Apr; 31(4):2260-2273. PubMed ID: 38668070
[TBL] [Abstract] [Full Text] [Related]
2. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
3. Defining distal splenopancreatectomy by the mesopancreas.
Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
[TBL] [Abstract] [Full Text] [Related]
4. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
[TBL] [Abstract] [Full Text] [Related]
5. Perioperative factors associated with survival following surgery for pancreatic cancer - a nationwide analysis of 473 cases from Denmark.
Spore LM; Dencker EE; Kvanner EA; Hansen CP; Burgdorf SK; Krohn PS; Kollbeck SLG; Storkholm JH; Sillesen M
BMC Surg; 2024 Mar; 24(1):76. PubMed ID: 38431571
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
7. Predicting the unpredictable: a robust nomogram for predicting recurrence in patients with ampullary carcinoma.
Chen R; Zhu L; Zhang Y; Cui D; Chen R; Guo H; Peng L; Xiao C
BMC Cancer; 2024 Feb; 24(1):212. PubMed ID: 38360582
[TBL] [Abstract] [Full Text] [Related]
8. Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas.
Michalski K; Schlötelburg W; Hartrampf P; Heinrich M; Serfling S; Buck AK; Werner RA; Kosmala A; Weich A
Mol Imaging Biol; 2024 Apr; 26(2):344-350. PubMed ID: 38332341
[TBL] [Abstract] [Full Text] [Related]
9. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
[TBL] [Abstract] [Full Text] [Related]
10. Improved Clinical staging System for Localized pancreatic cancer Using the ABC Factors: A TAPS Consortium Study.
Dekker EN; van Dam JL; Janssen QP; Besselink MG; DeSilva A; Doppenberg D; van Eijck CHJ; Nasar N; O'Reilly EM; Paniccia A; Prakash LR; Tzeng CD; Verkolf EMM; Wei AC; Zureikat AH; Katz MHG; Groot Koerkamp B;
J Clin Oncol; 2024 Apr; 42(12):1357-1367. PubMed ID: 38315954
[TBL] [Abstract] [Full Text] [Related]
11. Trends and disparities in access to minimally invasive distal pancreatectomy (midp): an eight-year analysis from the national cancer database.
Jehan FS; Khreiss M; Seth A; Aziz H
J Robot Surg; 2024 Jan; 18(1):52. PubMed ID: 38280048
[TBL] [Abstract] [Full Text] [Related]
12. [Survival of patients with pancreatic ductal adenocarcinoma].
Targarona J; Rivero L; Coayla G; Roman G; Rivas D; Legua S; Carrasco R
Rev Gastroenterol Peru; 2023; 43(4):300-308. PubMed ID: 38228295
[TBL] [Abstract] [Full Text] [Related]
13. Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.
Doppenberg D; Stoop TF; van Dieren S; Katz MHG; Janssen QP; Nasar N; Prakash LR; Theijse RT; Tzeng CD; Wei AC; Zureikat AH; Groot Koerkamp B; Besselink MG;
Ann Surg Oncol; 2024 Mar; 31(3):1919-1932. PubMed ID: 38170408
[TBL] [Abstract] [Full Text] [Related]
14. Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected pancreatic cancer.
Murthy P; Zenati MS; AlMasri SS; DeSilva A; Singhi AD; Paniccia A; Lee KK; Simmons RL; Bahary N; Lotze MT; Zureikat AH
J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237070. PubMed ID: 38150819
[TBL] [Abstract] [Full Text] [Related]
15. Inadequacy of the eighth edition of the American Joint Committee on cancer pancreatic cancer staging system for invasive carcinoma associated with premalignant lesions in the pancreas: an analysis using the National cancer Database.
Jung HS; Lee M; Han Y; Thomas AS; Yun WG; Cho YJ; Kluger MD; Jang JY; Kwon W
HPB (Oxford); 2024 Mar; 26(3):400-409. PubMed ID: 38114399
[TBL] [Abstract] [Full Text] [Related]
16. Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery.
Li B; Yin X; Ding X; Zhang G; Jiang H; Chen C; Guo S; Jin G
BMC Surg; 2023 Dec; 23(1):370. PubMed ID: 38066512
[TBL] [Abstract] [Full Text] [Related]
17. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer.
Stoop TF; Theijse RT; Seelen LWF; Groot Koerkamp B; van Eijck CHJ; Wolfgang CL; van Tienhoven G; van Santvoort HC; Molenaar IQ; Wilmink JW; Del Chiaro M; Katz MHG; Hackert T; Besselink MG;
Nat Rev Gastroenterol Hepatol; 2024 Feb; 21(2):101-124. PubMed ID: 38036745
[TBL] [Abstract] [Full Text] [Related]
18. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.
Shi W; Wartmann T; Accuffi S; Al-Madhi S; Perrakis A; Kahlert C; Link A; Venerito M; Keitel-Anselmino V; Bruns C; Croner RS; Zhao Y; Kahlert UD
Br J Cancer; 2024 Jan; 130(1):125-134. PubMed ID: 37950093
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of Multiple Liver cancer Scoring Systems.
Sun J; Qi C; Liu Y; Gao F; Fu X; Tian Y
Adv Biol (Weinh); 2024 Feb; 8(2):e2300301. PubMed ID: 37863815
[TBL] [Abstract] [Full Text] [Related]
[Next]
